1. Home
  2. XOMAP vs ATLCP Comparison

XOMAP vs ATLCP Comparison

Compare XOMAP & ATLCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo XOMA Corporation 8.625% Series A Cumulative Perpetual Preferred Stock

XOMAP

XOMA Corporation 8.625% Series A Cumulative Perpetual Preferred Stock

N/A

Current Price

$26.48

Market Cap

0.0

Sector

Health Care

ML Signal

N/A

Logo Atlanticus Holdings Corporation 7.625% Series B Cumulative Perpetual Preferred Stock no par value per share

ATLCP

Atlanticus Holdings Corporation 7.625% Series B Cumulative Perpetual Preferred Stock no par value per share

HOLD

Current Price

$22.30

Market Cap

0.0

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
XOMAP
ATLCP
Founded
N/A
N/A
Country
United States
United States
Employees
14
417
Industry
Biotechnology: Pharmaceutical Preparations
Finance: Consumer Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
N/A
N/A
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
XOMAP
ATLCP
Price
$26.48
$22.30
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
1.3K
7.8K
Earning Date
N/A
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$24.96
$20.46
52 Week High
$27.30
$25.00

Technical Indicators

Market Signals
Indicator
XOMAP
ATLCP
Relative Strength Index (RSI) 58.59 36.84
Support Level $26.05 $21.82
Resistance Level $26.87 $24.51
Average True Range (ATR) 0.21 0.79
MACD 0.12 -0.09
Stochastic Oscillator 52.80 47.30

Price Performance

Historical Comparison
XOMAP
ATLCP

About XOMAP XOMA Corporation 8.625% Series A Cumulative Perpetual Preferred Stock

XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates. The Company's drug royalty aggregator business is mainly focused on the acquisition of early to mid-stage clinical assets. Geographically, the company operates in Switzerland, the United States, Asia Pacific, Europe, and other regions.

About ATLCP Atlanticus Holdings Corporation 7.625% Series B Cumulative Perpetual Preferred Stock no par value per share

Atlanticus Holdings Corp is a financial technology company powering more inclusive financial solutions for Everyday Americans. It provides technology and other support services to lenders who offer an array of financial products and services to consumers. The company's products and services are reported through two reportable segments. Credit as a Service (CaaS) offers products including private label credit cards using the Fortiva and Curae brand names as well as merchant-associated brands and Auto Finance provides purchase and/or service loans secured by automobiles from or for, and also provides floor-plan financing for, a pre-qualified network of independent automotive dealers and automotive finance companies in the buy-here, pay-here used car business.

Share on Social Networks: